Stock

NexGen Energy

NXE

Uranium · Energy

Also trades as: NXE.TO CAD 11.40 (+0.26%) · 0V9D.L GBP 0.11 (-1.58%)

Price

$8.15

+0.05 (+0.62%)

Market Cap

$5.46B

Exchange

New York Stock Exchange

Winston Score

–

No score yet — nothing to grade.

This is a pre-revenue company — it has no sales yet, just exploration or development costs. There’s no operating business to grade on profitability, margins or cash flow, so the Winston Score stays blank until it starts booking revenue.

Track this stock — start free trial

Share count rising — dilution

+28.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 459.3M (2021) → 588.4M (2025)

§Winston Score History

The full picture

NexGen Energy is a Canadian uranium company focused on developing one of the largest undeveloped uranium deposits in the world. Its main asset is the Rook I Project, located in the Athabasca Basin in Saskatchewan, Canada. The company does not yet produce uranium but is working to build a mine that would supply uranium to nuclear power plants around the world.

NexGen does not currently earn revenue — it is a development-stage company spending money to build its mine rather than selling a product. It is funded through equity raises and has a strong competitive position because the Rook I deposit, called Arrow, is exceptionally large and high-grade compared to most uranium projects globally. The key growth driver is receiving final regulatory approvals and moving into construction, but the main risks are permitting delays, uranium price swings, and the long timeline before the company generates any actual cash flow.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

Reported EPS Growth

+173.3% YoY

Quarterly reporting periods ended:

30 Jun 2025: C$-0.15

30 Jun 2026: C$0.11

Reported/statutory EPS, not adjusted or underlying earnings. One-off items can affect this figure. Provider rounding can affect the growth rate.

YoY Growth Rate

Reported EPS increased year over year

R&D Spend

C$0/ year

Research and development spending

Insider Activity

6.7%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

~3 years

C$1.2B cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

C$1.2B cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

-4.5%

Weak — -4.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.33

Conservative — low debt load (0.33)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial